Provided by Tiger Trade Technology Pte. Ltd.

Novavax

9.42
+0.12001.29%
Post-market: 9.500.0799+0.85%19:59 EDT
Volume:6.12M
Turnover:58.93M
Market Cap:1.55B
PE:-6.21
High:9.87
Open:9.29
Low:9.23
Close:9.30
52wk High:11.97
52wk Low:6.20
Shares:164.43M
Float Shares:143.00M
Volume Ratio:1.18
T/O Rate:4.28%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.5181
EPS(LYR):2.58
ROE:-898.20%
ROA:-6.51%
PB:-8.12
PE(LYR):3.65

Loading ...

Novavax Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 12

Novavax Inc. Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Sep 11

Novavax Inc. Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Sep 10

Novavax Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Sep 05

Novavax Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 03

Novavax to Present at Cantor Global Healthcare Conference in Fireside Chat

Reuters
·
Sep 03

Unusually active option classes on open September 2nd

TIPRANKS
·
Sep 02

Novavax call volume above normal and directionally bullish

TIPRANKS
·
Sep 01

Novavax Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 01

Novavax Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 29

Novavax’s partners approved for Nuvaxovid formulation for vaccination season

TIPRANKS
·
Aug 28

Novavax's Partnership Strategy Continues to Deliver with Xfg-Adapted Nuvaxovid™ Approvals in the U.S., EU and Japan for 2026-2027 Vaccination Season

THOMSON REUTERS
·
Aug 28

Novavax, - Eligible for Royalties on Net Sales in U.S., EU, Japan for 2026-2027 Season

THOMSON REUTERS
·
Aug 28

Sanofi Spokesperson Says Nuvaxovid to be Available Across U.S. for 2026-27 Respiratory Virus Season

Reuters
·
Aug 28

Novavax Inc. Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Aug 27

Novavax Inc. Stock Rallies 6.5%, Outperforms Peers

Dow Jones
·
Aug 26

Novavax Inc. Stock Rises 6.2%, Outperforms Peers

Dow Jones
·
Aug 22

Novavax Inc. Stock Slips 4.2%, Underperforms Peers

Dow Jones
·
Aug 21

How Moderna’s Cancer Breakthrough Reversed Its Fortunes and Revived the Stock

Dow Jones
·
Aug 20

Novavax call volume above normal and directionally bullish

TIPRANKS
·
Aug 20